HCA Healthcare statement on supply of PPE
In January, our supply chain team began working around the clock to secure protective gear for our employees and for our physicians. Since that time, we have spared no expense in our efforts to acquire the PPE necessary to protect our employees, so they can continue to provide care to our patients. To date, we have distributed more than 35 million pieces of personal protective equipment and our hospitals continue to meet or exceed CDC standards recommended for crisis care.
HCA Healthcare statement on CARES Act
HCA Healthcare Previews 2020 Third Quarter Results; Will Return Approximately $6 Billion in CARES Act Funding. "We believe returning these taxpayer dollars is appropriate and the socially responsible thing to do," CEO Sam Hazen.
Full response to The New York Times
From day one, HCA Healthcare has addressed the pandemic with two clear objectives. The first, to protect our people—keep them safe and keep them employed—so they can care for our patients. The second, to protect the company so we can continue to serve our communities for years to come. At a time when hundreds of hospitals across the country are laying off and furloughing caregivers because there is no work for them due to significant declines in patient volume, HCA Healthcare has not laid off or furloughed a single caregiver due to the pandemic and we hope to avoid doing so in the future.
HCA Healthcare statement about not billing patients diagnosed with COVID-19 for related hospital care
HCA Healthcare hospitals do not bill patients who are diagnosed with COVID-19, whether they have insurance or not, for testing or hospital care related to the treatment of COVID-19.
While patients may receive documents, such as an Explanation of Benefits (EOB) from their insurance plan, with amounts listed, it’s important to remember that these are not patient bills, and we are not asking patients to pay for hospital services involved in the treatment of COVID-19.
Press Release: HCA Healthcare joins COVID-19 convalescent plasma study
HCA Healthcare (NYSE: HCA), one of the nation’s leading healthcare providers, today announced 172 of its affiliated hospitals are participating in a national study to test whether plasma from convalescent, or recovered, COVID-19 patients may help in the treatment of individuals currently sick from the virus. As part of the effort, these hospitals are seeking qualified plasma donors in 20 states.
Media Resources Archive
- HCA Healthcare statement on supply of PPE
- HCA Healthcare statement on CARES Act
- Full response to The New York Times
- HCA Healthcare joins COVID-19 convalescent plasma study
- HCA Healthcare to provide up to 1,000 ventilators as part of public-private collaboration to battle COVID-19
- Frist Foundation gives $1 million to HCA Healthcare Hope Fund in support of colleagues impacted by COVID-19
- HCA Healthcare statement on social media policy
- HCA Healthcare teams with Google Cloud and SADA on data portal to help communities respond to COVID-19
- Response to National Nurses United (NNU): Preparedness